Theraclion

📍 Malakoff, France🗓 Founded 2004👥 39 employees💰 Last funded Jan 2022
Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound. High Intensity Focused Ultrasound (HIFU) does not require incisions nor an operating room, leaves no scars, and allows patients an immediate return to their daily activities. Echotherapy, as the HIFU treatment method is called, concentrates therapeutic ultrasounds to an internal focal point from outside of the body. Theraclion has developed two CE-marked robotic platforms delivering echotherapy: SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules. Each representing the potential to replace millions of surgical procedures every year. Based in Malakoff (Paris), the Theraclion team is made up of 30 people, mainly in technological and clinical development.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2004
Founded
Investor geography1 country
France
2
Frequently asked questions
Who invested in Theraclion?
Theraclion has 2 investors on record on gritt.io and 1 late-stage investors.
When did Theraclion last raise funding?
The most recent investment in Theraclion recorded on gritt.io was in January 2022.
When was Theraclion founded?
Theraclion was founded in 2004.
What industry is Theraclion in?
Theraclion operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Theraclion based?
Theraclion is headquartered in Malakoff, France.